| Primary |
| Product Used For Unknown Indication |
51.3% |
| Hypertension |
26.1% |
| Blood Pressure Abnormal |
2.0% |
| Hypertension |
1.5% |
| Depression |
1.5% |
| Diuretic Therapy |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Hypothyroidism |
1.5% |
| Renal Disorder |
1.5% |
| Type 2 Diabetes Mellitus |
1.5% |
| Antidepressant Therapy |
1.0% |
| Atrial Fibrillation |
1.0% |
| Back Pain |
1.0% |
| Blood Pressure |
1.0% |
| Blood Pressure Increased |
1.0% |
| Neuralgia |
1.0% |
| Osteoporosis |
1.0% |
| Peripheral Nerve Injury |
1.0% |
| Polycythaemia Vera |
1.0% |
| Rheumatoid Arthritis |
1.0% |
|
| Toxicity To Various Agents |
20.0% |
| Vomiting |
8.9% |
| Weight Increased |
8.9% |
| Renal Failure Acute |
6.7% |
| Small Bowel Angioedema |
6.7% |
| Weight Decreased |
6.7% |
| Angioedema |
4.4% |
| Completed Suicide |
4.4% |
| Hypertension |
4.4% |
| Intestinal Ischaemia |
4.4% |
| Pneumonia |
4.4% |
| Anaphylactic Reaction |
2.2% |
| Arthralgia |
2.2% |
| Choking |
2.2% |
| Circulatory Collapse |
2.2% |
| Condition Aggravated |
2.2% |
| Diabetes Mellitus |
2.2% |
| Drug Hypersensitivity |
2.2% |
| Drug Ineffective |
2.2% |
| Drug Interaction |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
60.8% |
| Hypertension |
13.4% |
| Diabetes Mellitus |
4.1% |
| Plasma Cell Myeloma |
3.1% |
| Blood Pressure |
2.6% |
| Completed Suicide |
2.6% |
| Cardiac Disorder |
2.1% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Type 2 Diabetes Mellitus |
2.1% |
| Blood Pressure Abnormal |
1.0% |
| Chronic Myeloid Leukaemia |
1.0% |
| Dementia Alzheimer's Type |
1.0% |
| Blood Cholesterol Increased |
0.5% |
| Actinic Keratosis |
0.5% |
| Angina Pectoris |
0.5% |
| Atrial Fibrillation |
0.5% |
| Blood Cholesterol |
0.5% |
| Chest Pain |
0.5% |
| Fracture |
0.5% |
| Gastrointestinal Disorder |
0.5% |
|
| Toxicity To Various Agents |
25.5% |
| Exposure Via Ingestion |
10.6% |
| Vomiting |
10.6% |
| Completed Suicide |
8.5% |
| Renal Failure Acute |
8.5% |
| Shock |
4.3% |
| Syncope |
4.3% |
| Atrial Fibrillation |
2.1% |
| Blood Immunoglobulin G Increased |
2.1% |
| Cardiac Arrest |
2.1% |
| Death |
2.1% |
| Dehydration |
2.1% |
| Hyperkalaemia |
2.1% |
| Infection |
2.1% |
| Left Ventricular Hypertrophy |
2.1% |
| Muscle Spasms |
2.1% |
| Muscular Weakness |
2.1% |
| Musculoskeletal Chest Pain |
2.1% |
| Mycosis Fungoides |
2.1% |
| Oedema Peripheral |
2.1% |
|
| Concomitant |
| Plasma Cell Myeloma |
17.5% |
| Type 2 Diabetes Mellitus |
12.7% |
| Multiple Sclerosis |
10.6% |
| Product Used For Unknown Indication |
9.9% |
| Chronic Myeloid Leukaemia |
6.7% |
| Hepatitis C |
6.0% |
| Prostate Cancer Metastatic |
5.1% |
| Osteoporosis |
4.4% |
| Immunodeficiency Common Variable |
3.4% |
| Nephrogenic Anaemia |
3.0% |
| Depression |
2.6% |
| Relapsing-remitting Multiple Sclerosis |
2.6% |
| Actinic Keratosis |
2.5% |
| Breast Cancer |
2.5% |
| Myelodysplastic Syndrome |
2.3% |
| Gait Disturbance |
2.1% |
| Osteoporosis Prophylaxis |
1.9% |
| Colonoscopy |
1.6% |
| Diabetes Mellitus |
1.4% |
| Drug Use For Unknown Indication |
1.2% |
|
| Vomiting |
16.7% |
| Weight Decreased |
10.7% |
| Pancreatitis |
8.2% |
| White Blood Cell Count Decreased |
7.3% |
| Nausea |
5.2% |
| Pneumonia |
4.7% |
| Rash |
4.3% |
| Urinary Tract Infection |
4.3% |
| Pyrexia |
3.9% |
| Vision Blurred |
3.9% |
| Weight Increased |
3.9% |
| Fatigue |
3.4% |
| Somnolence |
3.4% |
| Urticaria |
3.4% |
| Dyspnoea |
3.0% |
| Myocardial Infarction |
3.0% |
| Pancreatitis Acute |
3.0% |
| Blood Pressure Increased |
2.6% |
| Diarrhoea |
2.6% |
| Paraesthesia |
2.6% |
|
